Venture
Genesis Therapeutics, Inc.
Latest Form D 2023-08-25- CIK 1775819
- State CA
- Biotechnology
- 3 Form D offerings since 2020-12-09
- Total sold
- $297M
- across 3 offerings
- Rounds
- 3
- Form D offerings since 2020-12-09
- Latest round
- $224M
- 2023-08-25 · 021-490705
- Investors
- 50
- on the latest round
Connected
named in its Form D filingsOfferings · since 2020-12-093 Form D offeringsExemptions506(b)People · Item 3EVAN FEINBERG + 6 moreInvestors · dashboardInferred investors
Genesis Therapeutics, Inc.CIK 1775819
Round timeline
amount sold · by first filed2023-08-25 · $224M
- 2020-12-09$49.5M021-382629
- 2022-12-23$23.9M021-468673
- 2023-08-25$224M021-490705
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($224M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-490705 | First filed2023-08-25 | Latest2023-08-25 | Sought$224M | Sold$224M | Investors50 | Exemptions506(b) |
| 021-468673 | First filed2022-12-23 | Latest2022-12-23 | Sought$23.9M | Sold$23.9M | Investors33 | Exemptions506(b) |
| 021-382629 | First filed2020-12-09 | Latest2020-12-09 | SoughtIndefinite | Sold$49.5M | Investors24 | Exemptions506(b) |
Who backs Genesis Therapeutics, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2023-08-25
| Name | Relationship |
|---|---|
| EVAN FEINBERG | RelationshipExecutive Officer, Director |
| BENJAMIN SKLAROFF | RelationshipExecutive Officer |
| WILLIAM MCCARTHY | RelationshipExecutive Officer |
| LEONARD BELL | RelationshipDirector |
| PEPTIBOON PRASIT | RelationshipExecutive Officer, Director |
| KRIS JENNER | RelationshipDirector |
| VIJAY PANDE | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2020-12-09
- Latest filing
- 2023-08-25
Who backs Genesis Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗